Cargando…
Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
SIMPLE SUMMARY: Pancreatic cancer is the fourth most common cancer-related cause of death in the United States and is usually asymptomatic in early stages. There is a scarcity of tests that facilitate early diagnosis or accurately predict the disease progression. To this end, biomarkers have been id...
Autores principales: | Giannis, Dimitrios, Moris, Dimitrios, Barbas, Andrew S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959127/ https://www.ncbi.nlm.nih.gov/pubmed/33802340 http://dx.doi.org/10.3390/cancers13051071 |
Ejemplares similares
-
The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer
por: Gyftopoulos, Argyrios, et al.
Publicado: (2022) -
Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
por: Khomiak, Andrii, et al.
Publicado: (2020) -
The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer
por: Maloney, Sarah, et al.
Publicado: (2023) -
Overview of MicroRNAs as Diagnostic and Prognostic Biomarkers for High-Incidence Cancers in 2021
por: Zhang, Chunyan, et al.
Publicado: (2022) -
Validation of the 8th Edition American Joint Commission on Cancer (AJCC) Gallbladder Cancer Staging System: Prognostic Discrimination and Identification of Key Predictive Factors
por: Giannis, Dimitrios, et al.
Publicado: (2021)